HomeCompareNHI vs AXON

NHI vs AXON: Dividend Comparison 2026

NHI yields 4.42% · AXON yields 0.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NHI wins by $2.3K in total portfolio value
10 years
NHI
NHI
● Live price
4.42%
Share price
$82.41
Annual div
$3.64
5Y div CAGR
-16.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.6K
Annual income
$80.50
Full NHI calculator →
AXON
AXON
● Live price
0.48%
Share price
$415.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$49.72
Full AXON calculator →

Portfolio growth — NHI vs AXON

📍 NHI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHIAXON
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHI + AXON cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHI pays
AXON pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHI
Annual income on $10K today (after 15% tax)
$375.44/yr
After 10yr DRIP, annual income (after tax)
$68.43/yr
AXON
Annual income on $10K today (after 15% tax)
$40.96/yr
After 10yr DRIP, annual income (after tax)
$42.26/yr
At 15% tax rate, NHI beats the other by $26.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHI + AXON for your $10,000?

NHI: 50%AXON: 50%
100% AXON50/50100% NHI
Portfolio after 10yr
$21.5K
Annual income
$65.11/yr
Blended yield
0.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AXON right now

NHI
Analyst Ratings
5
Buy
12
Hold
1
Sell
Consensus: Hold
Price Target
$85.20
+3.4% upside vs current
Range: $83.00 — $88.00
Altman Z
2.1
Piotroski
6/9
AXON
Analyst Ratings
15
Buy
4
Hold
Consensus: Buy
Price Target
$750.00
+80.7% upside vs current
Range: $690.00 — $820.00
Altman Z
6.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHI buys
0
AXON buys
0
No recent congressional trades found for NHI or AXON in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHIAXON
Forward yield4.42%0.48%
Annual dividend / share$3.64$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-16.8%0%
Portfolio after 10y$22.6K$20.3K
Annual income after 10y$80.50$49.72
Total dividends collected$2.0K$490.00
Payment frequencyquarterlyquarterly
SectorREITStock
Analyst consensusHoldBuy
Analyst price target$85.20$750.00

Year-by-year: NHI vs AXON ($10,000, DRIP)

YearNHI PortfolioNHI Income/yrAXON PortfolioAXON Income/yrGap
1← crossover$11,067$367.49$10,748$48.18+$319.00NHI
2$12,158$316.25$11,549$48.40+$609.00NHI
3$13,280$270.15$12,406$48.61+$874.00NHI
4$14,439$229.43$13,323$48.80+$1.1KNHI
5$15,643$193.97$14,305$48.98+$1.3KNHI
6$16,902$163.41$15,355$49.14+$1.5KNHI
7$18,222$137.28$16,479$49.30+$1.7KNHI
8$19,613$115.09$17,682$49.45+$1.9KNHI
9$21,082$96.32$18,970$49.59+$2.1KNHI
10$22,638$80.50$20,347$49.72+$2.3KNHI

NHI vs AXON: Complete Analysis 2026

NHIREIT

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Full NHI Calculator →

AXONStock

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Full AXON Calculator →
📬

Get this NHI vs AXON comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHI vs SCHDNHI vs JEPINHI vs ONHI vs KONHI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.